NeuroMetBench reproducibility package
Description
NeuroMetBench is a patient-aware evidence-bounding methodology for evaluating transcript-derived metabolic representations across heterogeneous proteogenomic contexts. Version 2.1.2 adds revision-stage patient-influence and pathway-specificity stress tests, an internally preanalysis-frozen orthogonal measured-metabolomics sensitivity in the Wang/CPTAC glioblastoma cohort, and a recovered reaction-identity/artifact-integrity firewall for historical METAFlux outputs. The new evidence is deliberately asymmetric: LSCC pathway specificity is supported exploratorily, CNS specificity replication is not supported, and correspondence between the transcript-derived serine score and measured L-serine remains weak and uncertain. Historical solver optimality/KKT evidence is not reconstructed, and prior adverse results and claim ceilings remain preserved. Licensing is mixed by file: NeuroMetBench-authored material is MIT-licensed, while the minimal redistributed cBioPortal/Wang-CPTAC input subset remains under ODbL 1.0. The Zenodo record should declare both licenses.
Notes
Files
NeuroMetBench_v2.1.2_reproducibility_release.zip
Additional details
Related works
- Is supplement to
- Software: https://github.com/build33Mercury/NeuroMetBench (URL)
Software
- Repository URL
- https://github.com/build33Mercury/NeuroMetBench